Friday, July 10, 2026

Drug profile · INN

para-aminosalicylic acid

para-aminosalicylic acid (GRANUPAS (PREVIOUSLY PARA-AMINOSALICYLIC ACID LUCANE)) is a dihydrofolate reductase inhibitor.

EMA: withdrawn Antiinfectives for systemic use (J04) J04AA01
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — para-aminosalicylic acid
Class
Antiinfectives for systemic use (J04)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

para-aminosalicylic acid (GRANUPAS (PREVIOUSLY PARA-AMINOSALICYLIC ACID LUCANE)) is a dihydrofolate reductase inhibitor.

Key facts

INN para-aminosalicylic acid
Brand GRANUPAS (PREVIOUSLY PARA-AMINOSALICYLIC ACID LUCANE)
Mechanism Dihydrofolate reductase inhibitor
Target Dihydrofolate reductase
Therapeutic class Antiinfectives for systemic use (J04)
ATC code J04AA01

Mechanism of action

Dihydrofolate reductase inhibitor

Primary target: Dihydrofolate reductase

Approval history

Authority Status Date
EMA withdrawn

Related & competitor drugs

  1. aminosalicylate sodium Dihydrofolate reductase inhibitor
  2. atazanavir sulfate Antiinfectives for systemic use (J05)
  3. colistimethate sodium Antiinfectives for systemic use (J01)
  4. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  5. daptomycin Antiinfectives for systemic use (J01)
  6. darunavir Antiinfectives for systemic use (J05)

Frequently asked questions

What is para-aminosalicylic acid?

para-aminosalicylic acid (GRANUPAS (PREVIOUSLY PARA-AMINOSALICYLIC ACID LUCANE)) is a dihydrofolate reductase inhibitor.

What is the brand name for para-aminosalicylic acid?

GRANUPAS (PREVIOUSLY PARA-AMINOSALICYLIC ACID LUCANE) is a marketed brand name for para-aminosalicylic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.